Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Meiji Seika antibiotic scheduled for launch in Europe in 1998

March 26, 1997

Fujisawa obtains natural antifungal agent

March 26, 1997

Novel antibiotic isolated by Kitasato Institute and Chinese Academy of Medical Science

March 26, 1997

CytoTAb shows potential for use in the treatment of malaria

March 24, 1997

New formulation of podofilox receives FDA approval

March 24, 1997

First clinical trial results reported for MEDI-493

March 24, 1997

Freeze-dried fibrin-antibiotic complex for osteomyelitis

March 21, 1997

DU-6859a and liver dysfunction

March 21, 1997

Phase III results for HNK20

March 21, 1997

New cephalosporins from Kyoto Pharmaceutical Industries

March 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...